Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Flashfix** appears to be a topical acne-care product line marketed under the Conscious Chemist brand rather than a single well-defined pharmaceutical drug entity. Publicly available product listings identify Flashfix formulations such as an acne treatment serum and acne-control gel cream containing **salicylic acid 2%** with additional cosmetic or skin-care ingredients including zinc PCA, willow bark extract, lactic acid, and various botanical extracts. Based on those marketed formulations, Flashfix is intended for acne-prone skin to help unclog pores, reduce excess sebum, and limit breakouts through keratolytic and comedolytic activity associated with salicylic acid, but the exact active-ingredient composition varies by product within the Flashfix line.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Flashfix.